PATENT
China leading generative AI patents race, UN report says
Generative AI, which produces text, images, computer code and even music from existing information, is exploding with more than 50,000 patent applications filed in the past decade, according to the World Intellectual Property Organization (WIPO), which oversees a system for countries to share recognition of patents.
India issued one lakh patents in 2024, ten years back it was just 6000: Piyush Goyal
India has seen a significant rise in the number of patents granted, reaching around one lakh in 2024, a substantial increase from the 6,000 patents issued annually a decade ago, according to Union Minister of Commerce and Industry Piyush Goyal. The announcement was made during an outreach program with industry leaders and stakeholders in Hyderabad, Telangana.
India to make drugs for diabetes, obesity under PLI by 2026, says report
India plans to incentivize local manufacturing of GLP-1 drugs, crucial for treating diabetes and obesity, starting in 2026, as per a government official speaking to Reuters. These drugs, originally approved for diabetes treatment, are also used for obesity due to their ability to slow digestion and reduce appetite. Novo Nordisk's patent on semaglutide, a key ingredient in popular drugs like Wegovy and Ozempic, is set to expire in India by 2026. Indian companies are already preparing to manufacture these drugs under the government's production-linked incentive (PLI) scheme.
Indian Pharma exports: 'USD 10 billion opportunity up for grabs in off patent drug market by 2029'
A senior official of the Pharmexcil said drugs such as Merck's Pembrolizumab (Keytruda) whose revenue were at USD 25 billion and Bristol-Myers Squibb's Eliquis (Apixaban)-USD 12 billion, among others would be off-patented in the next few years.
Infosys working on 225 GenAI programs for clients; enterprise AI will take years to unfold: Nilekani
At Infosys' 43rd annual general meeting, cofounder and chairman Nandan Nilekani talked of the nascent stage of the Generative AI revolution. He also said consumer AI will see rapid adoption but enterprise AI will take several years to mature and have a widespread impact.
Sun Pharma, Cipla enter licensing agreement with Takeda to market novel gastrointestinal drug in India
Sun Pharma and Cipla have entered a licensing deal with Takeda Pharmaceutical to commercialize Vonoprazan tablets in India. This novel drug, used to treat Gastroesophageal Reflux Disease (GERD) and related acid disorders, will be marketed by Sun Pharma as Voltapraz and by Cipla under their own brands.
- Go To Page 1
Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in India
Sun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in India. The agreement allows Sun Pharma to commercialize 10 mg and 20 mg tablets of Vonoprazan, an innovative treatment for acid peptic disorders, under a non-exclusive patent license.
Look-alike, sounding similar drugs likely to face strict action
Earlier, in January India's Drug Technical Advisory Board (DTAB), India's apex drug advisory body, deliberated on the issue of same brand name (including look-alike and sound-alike ones) for different category of products and it suggested that to ensure patient safety, the manufacturing and marketing of different drugs with same brand name should "not be allowed."
Biocon seeks partner to test generic Wegovy, Ozempic in China
India's Biocon is seeking a Chinese partner to conduct clinical trials on generic versions of Novo Nordisk's popular diabetes drug Ozempic and weight loss treatment Wegovy. Biocon aims to eventually launch these generics globally, with plans to find a partner for the trials on over 500 patients in China, citing the substantial investment required. The move comes ahead of the patent protection expiry on key ingredients in the drugs in 2026.
Best Agrolife to launch new insecticide for resistant pests in July
Best Agrolife Ltd has obtained regulatory approval for its new patented insecticide formulation named Nemagen, designed to combat resistant pests causing significant crop damage. The company plans to launch Nemagen in July. According to Best Agrolife, lepidopteran pests such as borers have become resistant to existing insecticides, leading to substantial crop losses ranging from 30% to 50%.
Ozempic frenzy lures rich Indians to brave the gray market
People are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying counterfeit formulas online, and importing boxes from Europe. The treatments have sparked extensive media coverage, fueling a high demand. According to Goldman Sachs Research, the anti-obesity medication market could hit $100 billion by 2030. In contrast, Indians have largely been observers in this global frenzy over the new weight-loss solutions.
Govt allows global tenders to access 120 key, patented drugs
In what could ease access to some patented medicines, the government has allowed global tenders to be floated for procurement of 120 drugs, including anti-diabetic medication Semaglutide, after the health ministry raised concerns over lack of domestic options.
US Supreme Court bars 'Donald Trump too small' trademark
The U.S. Supreme Court barred on Thursday a federal trademark for the phrase "Trump Too Small" - an irreverent criticism of former President Donald Trump - rejecting a California lawyer's claim that the trademark denial violated his constitutional free speech rights.
SLCM Group secures second Agri Reach application patent for real-time quality control monitoring in warehouses
SLCM acquires second Agri Reach patent for real-time quality control data monitoring in warehouses, bolstering agricultural ecosystem self-reliance.
Affle India is this week's top stock; why analysts are bullish
The management aims for over 20% revenue growth in 2024-25 and is optimistic about better pricing and margin improvement. Analysts expect the near-term pressure from developed markets to subside in the current financial year. Should you invest in Affle India?
Torrent Pharma signs non-exclusive patent licensing pact with Takeda Pharma for Vonoprazan
A 2019 study published by the Indian Journal of Gastroenterology revealed that the prevalence of GERD in the Indian population is around 8.2%, with a higher prevalence of around 11.1% in the urban population. According to AWACS MAT April 2024 data, the Indian market for treatments used in GERD is valued at Rs 8,064 crore, growing at 8% CAGR over the last four years.
How to navigate IP challenges in the rise of social media
While social media has created immense opportunities for engagement and expression, it has also raised a myriad of legal challenges, particularly concerning intellectual property (IP) rights including issues around content ownership, digital rights management, deep fakes etc.
WIPO treaty a big win for India & global south: Commerce ministry
India and the Global South celebrate a significant win with the WIPO treaty on intellectual property, genetic resources, and traditional knowledge. The treaty introduces a new disclosure requirement for patent applicants based on genetic resources, providing added protection to Indian resources and knowledge in countries without disclosure obligations.
Global pact on genetic resources, associated traditional knowledge big win for India: Govt
Members of the Geneva-based World Intellectual Property Organization (WIPO) have concluded an agreement that creates a mandatory disclosure requirement on the patent applicant, when a claimed invention is based on genetic resources.
WIPO concludes new treaty to protect genetic resources, traditional knowledge; India plays key role
Members of the World Intellectual Property Organization (WIPO) have reached an agreement mandating patent applicants to disclose the country of origin or source of genetic resources if their claimed invention is based on these materials or associated traditional knowledge. This treaty, adopted at a Diplomatic Conference in Geneva after two weeks of negotiations involving 192 countries and 86 observers, aims to protect Indian genetic resources and traditional knowledge from misappropriation.
Coromandel launches 10 new products to boost crop yields
Coromandel has partnered with Japan's ISK to launch Prachand, a patented product using Japanese technology to protect paddy crops from pests like stem borers and leaf folders that can cause up to 70 per cent yield losses. It has also developed a formulation to effectively combat fall armyworm, a highly destructive pest that damages up to 30 per cent of the corn crop annually in India.
Google celebrates 195 years of the Accordion's patent with musical doodle: Know history, significance and global influence
Google celebrated the 195th anniversary of the accordion's patent with a special doodle on May 23, 2024. The doodle featured a musical theme, integrating the 'Google' logo within the bellows of an accordion. Highlighting the instrument's German origins and its impact on various music genres, Google explained how the accordion gained popularity in the late 1800s and became a staple in folk, Cajun, tango, and Latino polka music. T
Microsoft hit with $242 million US verdict in Cortana patent lawsuit
Microsoft ordered to pay $242 million to IPA for infringing IPA patent with Cortana. IPA under Wi-LAN. Lawsuit filed in 2018. Microsoft denies infringement. IPA also sued Google and Amazon.
Mahindra, Tata Motors receive record patent approvals in FY24
M&M's patents cover a range of functions, such as powertrain (ICE & EV), vehicle mechanical systems, electronics, manufacturing processes, electric tractors, and advanced engineering, among others. Tata Motors also received its highest-ever grant of 333 patents during the last fiscal, taking its total tally of granted patents to over 850.
India granted over 1 lakh patents in FY24: Official
India granted 1.03 lakh patents in FY 2023-24 with a focus on economic value and strengthening the IP position. The IP office ensures no delays with 40% applications cleared within 30 months, reflecting confidence in research commercialization.
India leads the world in AI’s skill penetration; lags on investments
India is number one in the world in terms of relative AI skill penetration, and is in the top four globally when it comes to relative AI hiring rate.
Delhi HC dismisses Google's appeal against messaging patent decision
In addition, Google was fined Rs 1 lakh for not revealing true facts and for its failure to disclose information regarding the refusal of a patent by the European Patent Office (EPO) for lack of an inventive step.
Indian patent office grants 1 lakh patents in past year
"Every 6 minutes one technology is seeking IP protection in India. In 2023, an all-time high of 90,300 patent applications were received. Patent office granted over one lakh patents in the last one year (15-Mar-2023 to 14-Mar-2024). Every working day, 250 patents were granted," the commerce and industry ministry said.
Delhi HC bars Natco Pharma from selling cancer drug Olaparib
The Delhi High Court has prohibited Natco Pharma from producing and selling the cancer drug Olaparib, marketed as 'BRACANAT' or under any other name, until further notice. The court's decision came in response to a lawsuit by Kudos Pharmaceuticals, which claimed that Natco was infringing on its patent for Olaparib. The court found Natco's challenge to the patent's validity unconvincing, leading to the injunction. Natco had sought to revoke Kudos' patent only after the lawsuit was filed, despite no previous opposition to it.
Load More
